Mammary serum antigen (MSA), ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 2953-2954

  Heinze, T ^a   Schurenkamper P ^a   Minguillon, C ^a   Lichtenegger, W ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Breast cancer; CA 15 3; CA 549; CEA; Mammary serum antigen; Prognosis

Indexed keywords

CA 15-3 ANTIGEN; CA 549 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN D; ESTROGEN RECEPTOR; GLYCOPROTEIN; HORMONE RECEPTOR; MAMMARY SERUM ANTIGEN; PROGESTERONE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; BLOOD LEVEL; BREAST CANCER; CANCER GRADING; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GLYCOPROTEINS; HUMANS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 1842415405     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Tjandra JJ, Busmanis I, Russell IS, Collins JP, Reed RG, McKenzie IFC: The association of mammary serum antigen (MSA) with the histopathological findings in localized breast cancer. Br J Cancer 58: 815-817, 1988.
2. Sacks NPMm, Stacker SA, Thompson CA, Collins JP, Russell IS, Sullivan JA, McKenzie IFC: Comparison of mammary serum' antigen (MSA) and Ca 15-3 levels in the serum of patients with breast cancer. BrJ Cancer 56: 820-826, 1987.
3. Layton GT, Golder J, Johnston S, Mc Guckin MA, Ward B, Lo T, Williams P, Bishop JF, Jeal P, Francis P, Xing PX, Mc Kenzie IFC: Evaluation of an inhibition enzyme immunoassay kit for mammary serum antigen (MSA) J Tumor Marker Oncol 6: 1-8, 1991.